Cargando…

Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment

Membrane readers take part in trafficking and signaling processes by localizing proteins to organelle surfaces and transducing molecular information. They accomplish this by engaging phosphoinositides (PIs), a class of lipid molecules which are found in different proportions in various cellular memb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kervin, Troy A., Wiseman, Brittany C., Overduin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340361/
https://www.ncbi.nlm.nih.gov/pubmed/34368138
http://dx.doi.org/10.3389/fcell.2021.690461
_version_ 1783733754758430720
author Kervin, Troy A.
Wiseman, Brittany C.
Overduin, Michael
author_facet Kervin, Troy A.
Wiseman, Brittany C.
Overduin, Michael
author_sort Kervin, Troy A.
collection PubMed
description Membrane readers take part in trafficking and signaling processes by localizing proteins to organelle surfaces and transducing molecular information. They accomplish this by engaging phosphoinositides (PIs), a class of lipid molecules which are found in different proportions in various cellular membranes. The prototypes are the PX domains, which exhibit a range of specificities for PIs. Our meta-analysis indicates that recognition of membranes by PX domains is specifically controlled by modification of lysine and arginine residues including acetylation, hydroxyisobutyrylation, glycation, malonylation, methylation and succinylation of sidechains that normally bind headgroups of phospholipids including organelle-specific PI signals. Such metabolite-modulated residues in lipid binding elements are named MET-stops here to highlight their roles as erasers of membrane reader functions. These modifications are concentrated in the membrane binding sites of half of all 49 PX domains in the human proteome and correlate with phosphoregulatory sites, as mapped using the Membrane Optimal Docking Area (MODA) algorithm. As these motifs are mutated and modified in various cancers and the responsible enzymes serve as potential drug targets, the discovery of MET-stops as a widespread inhibitory mechanism may aid in the development of diagnostics and therapeutics aimed at the readers, writers and erasers of the PI code.
format Online
Article
Text
id pubmed-8340361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83403612021-08-06 Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment Kervin, Troy A. Wiseman, Brittany C. Overduin, Michael Front Cell Dev Biol Cell and Developmental Biology Membrane readers take part in trafficking and signaling processes by localizing proteins to organelle surfaces and transducing molecular information. They accomplish this by engaging phosphoinositides (PIs), a class of lipid molecules which are found in different proportions in various cellular membranes. The prototypes are the PX domains, which exhibit a range of specificities for PIs. Our meta-analysis indicates that recognition of membranes by PX domains is specifically controlled by modification of lysine and arginine residues including acetylation, hydroxyisobutyrylation, glycation, malonylation, methylation and succinylation of sidechains that normally bind headgroups of phospholipids including organelle-specific PI signals. Such metabolite-modulated residues in lipid binding elements are named MET-stops here to highlight their roles as erasers of membrane reader functions. These modifications are concentrated in the membrane binding sites of half of all 49 PX domains in the human proteome and correlate with phosphoregulatory sites, as mapped using the Membrane Optimal Docking Area (MODA) algorithm. As these motifs are mutated and modified in various cancers and the responsible enzymes serve as potential drug targets, the discovery of MET-stops as a widespread inhibitory mechanism may aid in the development of diagnostics and therapeutics aimed at the readers, writers and erasers of the PI code. Frontiers Media S.A. 2021-07-22 /pmc/articles/PMC8340361/ /pubmed/34368138 http://dx.doi.org/10.3389/fcell.2021.690461 Text en Copyright © 2021 Kervin, Wiseman and Overduin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Kervin, Troy A.
Wiseman, Brittany C.
Overduin, Michael
Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title_full Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title_fullStr Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title_full_unstemmed Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title_short Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
title_sort phosphoinositide recognition sites are blocked by metabolite attachment
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340361/
https://www.ncbi.nlm.nih.gov/pubmed/34368138
http://dx.doi.org/10.3389/fcell.2021.690461
work_keys_str_mv AT kervintroya phosphoinositiderecognitionsitesareblockedbymetaboliteattachment
AT wisemanbrittanyc phosphoinositiderecognitionsitesareblockedbymetaboliteattachment
AT overduinmichael phosphoinositiderecognitionsitesareblockedbymetaboliteattachment